Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation

Abstract

Virtually all mammalian cells express two seemingly redundant cyclin–D-dependent kinases (Cdk4 and Cdk6) and three partner cyclins (D1, D2 and D3) essential for the G1–S transition, with predominant expression of Cdk4 and D1 in mesenchymal cells and Cdk6 and D3 in hematopoietic cells. We recently found two novel functions for Cdk6 executed in fibroblasts although unlike Cdk4 it is dispensable for their proliferation. In the rat fibroblast NRK-49F cells, oncogenic stimulation recruits Cdk6 to participate in a step of the cell cycle start that seems to be critical for anchorage-independent S-phase onset. Among the kinase-D-type cyclin combinations, the Cdk6–cyclin-D3 complex has a unique ability to evade inhibition by cyclin-dependent kinase inhibitors and thereby control the cell's proliferative competence under growth-suppressive conditions. We describe here that 2–5-fold overexpression of both Cdk6 and D3 enhances by 5×103–106-fold the susceptibility of the BALB/c3T3 and C3H10T1/2 mouse fibroblast lines to ultraviolet irradiation- as well as 3-methylcholanthrene-induced transformation. This result suggests that deregulated expression of Cdk6 and cyclinD3 may predispose cells to malignant transformation, supporting the recent finding that cyclin D3 activated by chromosomal rearrangement is the causative gene of non-Hodgkin B lymphoma, in which Cdk6 is the major partner kinase.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Bartkova J, Lukas J, Strauss M and Bartek J . (1998). Oncogene, 17, 1027–1037.

  • Cenciarelli C, Santa FD, Puri PL, Mattei E, Ricci L, Bucci F, Felsani A and Caruso M . (1999). Mol. Cell. Biol., 19, 5203–5217.

  • Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina E, Sorio C, Beneditti A, Vinante E, Pizzolo G and Inghirami G . (1998). Am. J. Pathol., 152, 209–217.

  • Corcoran MM, Mould SJ, Orchard JA, Ibbotson RE, Chapman RM, Boright AP, Platt C, Tsui LC, Scherer SW and Oscier DG . (1999). Oncogene, 18, 6271–6277.

  • Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ and Cavenee WK . (1997). Cancer Res., 57, 1250–1254.

  • Dulic V, Lees E and Reed SI . (1992). Science, 257, 1958–1961.

  • Easton J, Wei T, Lahti JM and Kidd VJ . (1998). Cancer Res., 58, 2624–2632.

  • Ebert MPA, Hernberg S, Fei G, Sokolowski A, Schulz HU, Lippert H and Malfertheiner P . (2001). J. Cancer Res. Clin. Oncol., 127, 449–454.

  • Fang F, Orend G, Watanabe N, Hunter T and Ruoslahti E . (1996). Science, 271, 499–502.

  • Hall M and Peters G . (1996). Adv. Cancer Res., 68, 67–108.

  • Herzinger T and Reed SI . (1998). J. Biol. Chem., 273, 14958–14961.

  • Hunter T and Pines J . (1994). Cell, 79, 573–582.

  • Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB . (1993). Proc. Natl. Acad. Sci. USA, 90, 9026–9030.

  • Jinno S, Hung SC and Okayama H . (1999a). Oncogene, 18, 565–571.

  • Jinno S, Hung SC, Yamamoto H, Lin J, Nagata A and Okayama H . (1999b). Proc. Natl. Acad. Sci. USA, 96, 13197–13202.

  • Jinno S, Yageta M, Nagata A and Okayama H . (2002). Oncogene, 21, 1777–1784.

  • Kakunaga T . (1985). IARC Scientific Publication NO. 67: Transformation Assay of Established Cell Lines, Mechanisms and Application. Kakunaga T and Yamasaki H (eds). Oxford University Press: New York, pp 55–73.

    Google Scholar 

  • Kakunaga T and Crow JD . (1980). Science, 209, 505–507.

  • Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S and Uehara Y . (1997). Oncogene, 15, 629–637.

  • Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR and Robert JM . (1992). Science, 257, 1689–1694.

  • Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P and Rosen N . (1994). Oncogene, 9, 1925–1929.

  • Lien HC, Lin CW, Huang PH, Chang ML and Hsu SM . (2000). Lab. Invest., 80, 893–900.

  • Lin J, Jinno S and Okayama H . (2001). Oncogene, 20, 2000–2009.

  • Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A . (1991). Nature, 350, 512–515.

  • Okayama H, Nagata A, Jinno S, Murakami H, Tanaka K and Nakashima N . (1996). Adv. Cancer Res., 69, 17–62.

  • Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM and Greene LA . (1998). J. Cell Biol., 143, 457–467.

  • Pines J . (1995). Semin. Cancer Biol., 6, 63–72.

  • Reznikoff CA, Brankow DW and Heidelberg C . (1973). Cancer Res., 33, 3231–3238.

  • Robles AI and Conti CJ . (1995). Carcinogenesis, 16, 781–786.

  • Rogatsky I, Trowbridge JM and Garabedian MJ . (1997). Mol. Cell. Biol., 17, 3181–3193.

  • Schauer IE, Siriwardana S, Langan TA and Sclafani RA . (1994). Proc. Natl. Acad. Sci. USA, 91, 7827–7831.

  • Shaughnessy Jr J, Gabrea A, Qi Y, Brents L, Zhan FH, Tian E, Sawyer J, Barlogie B, Bergsagel PL and Kuehl M . (2001). Blood, 98, 217–223.

  • Sherr CJ . (1996). Science, 274, 1672–1677.

  • Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberg B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJS . (2001). Blood, 98, 2837–2844.

  • Timmermann S, Hinds PW and Munger K . (1997). Cell Growth Differ., 8, 361–370.

  • Van den Heuvel and Harlow E . (1993). Science, 262, 2050–2054.

  • Wang J and Walsh K . (1996). Cell Growth Differ., 7, 1471–1478.

  • Weinberg RA . (1995). Cell, 81, 323–330.

  • Zhu XY, Ohtsubo M, Bohmer RM, Roberts JM and Assoian RK . (1996). J. Cell Biol., 133, 391–403.

Download references

Acknowledgements

This work was supported by grants from the Ministry of Education, Science and Culture, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroto Okayama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Q., Lin, J., Jinno, S. et al. Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 22, 992–1001 (2003). https://doi.org/10.1038/sj.onc.1206193

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206193

Keywords

This article is cited by

Search

Quick links